{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:23:26Z","timestamp":1791267806591,"version":"4.1.0"},"reference-count":96,"publisher":"Japan Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1507\/endocrj.k09e-204","type":"journal-article","created":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T05:59:44Z","timestamp":1256623184000},"page":"827-841","source":"Crossref","is-referenced-by-count":39,"title":["Surgical Approach in Hereditary Hyperparathyroidism"],"prefix":"10.1507","volume":"56","author":[{"given":"Francesco","family":"TONELLI","sequence":"first","affiliation":[{"name":"Surgical Unit, Department of Clinical Physiopathology, and Regional Center for Hereditary Endocrine Tumors, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"MARCUCCI","sequence":"additional","affiliation":[{"name":"Surgical Unit, Department of Clinical Physiopathology, and Regional Center for Hereditary Endocrine Tumors, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"GIUDICI","sequence":"additional","affiliation":[{"name":"Surgical Unit, Department of Clinical Physiopathology, and Regional Center for Hereditary Endocrine Tumors, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"FALCHETTI","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"BRANDI","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Marx SJ, Simonds WF, Agarwal SK, <I>et al. <\/I>(2002) Hyperparathyroidism in hereditary syndromes: special expression and special managements. <I>J Bone Miner Res <\/I>17 (Suppl 2): 37-43."},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.12.5658"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Burgess JR, David R, Greenaway TM, <I>et al. <\/I>(1999) Osteoporosis multiple endocrine neoplasia type1. <I>Arch Surg <\/I>134: 1119-23.","DOI":"10.1001\/archsurg.134.10.1119"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Marx SJ, Menczel J, Campbell, <I>et al. <\/I>(1991) Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1. <I>Clin Endocrinol <\/I>35: 521-526.","DOI":"10.1111\/j.1365-2265.1991.tb00938.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Arnalsteen LC , Alesina PF, Quireux JL, <I>et al. <\/I>(2002) Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. <I>Surgery <\/I>132:1119-25","DOI":"10.1067\/msy.2002.128607"},{"key":"6","unstructured":"6. Kaimps JL, Quan-Yang Duh, Demeure M, <I>et al. <\/I>(1992) Hyperparathyroidism in multiple endocrine neoplasia syndrome. <I>Surgery <\/I>112:1080-88."},{"key":"7","unstructured":"7. Amorosi A, Nesi G, Spini S, <I>et al. <\/I>(1994) Histologic features of parathyroid hyperplasia in multiple endocrine neoplasia type 1 (MEN -1). Diagnostic and surgical implications. <I>Acta Chir Austriaca <\/I>26 ( Suppl. n. 112) : 13-5."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bonjer HJ, Bruining HA, Bierkenhager JC, <I>et al<\/I>. (1992) Single and multiglandular disease in primary hyperparathyroidism : clinical follow-up, histopathology and flow cytometric DNA analysis. <I>World J Surg <\/I>16 :737-44.","DOI":"10.1007\/BF02067373"},{"key":"9","unstructured":"9. Wang CA. (1976) The anatomic basis of parathyroid surgery. <I>Ann Surg <\/I>183:271-5."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Brandi ML, Aurbach GD, Fitzpatrick LA. (1986) Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. <I>N Engl J Med <\/I>314:1287-93.","DOI":"10.1056\/NEJM198605153142004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Clark OH, Way LW, Hunt TW. (1976) Recurrent hyperparathyroidism. <I>Ann Surg <\/I>184: 391-401.","DOI":"10.1097\/00000658-197610000-00001"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000124383.98416.8d"},{"key":"13","unstructured":"13. Metz DC, Jensen RT, Bale AE, <I>et al<\/I>. (1994) Multiple endocrine neoplasia type 1. In: Bilezikian JP, Marcus R, Levine MA,eds:The parathyroids. Basic and clinicalconcepts. Raven Press, New York, 591-646."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hellman P, Skogseid B, Juhlin C, <I>et al<\/I>. (1992) Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1. <I>World J Surg <\/I>16:718-25.","DOI":"10.1007\/BF02067367"},{"key":"15","unstructured":"15. Bilezikian JP, Potts JT, Fuleihan GE, <I>et al<\/I>. (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a prospective for the 21<SUP>st<\/SUP> century. <I>J Bone Mineral Res <\/I>17(Suppl 2):2-11."},{"key":"16","unstructured":"16. Tonelli F, Amorosi A, Tommasi MS, <I>et al<\/I>. (1990) Fisiopatologia e diagnosi dell&rsquo;iperparatiroidismo. Atti 92&deg; Congr. SIC; Roma, 21-25 ottobre, Luigi Pozzi srl ed.-Roma."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tonelli F, Spini S, Tommasi MS, <I>et al. <\/I>(2000) Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type 1 syndrome and hyperparathyroidism. <I>World J Surg <\/I>24:556-63.","DOI":"10.1007\/s002689910091"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kivlen M., Bartlett DL, Libutti SK, <I>et al<\/I>. (2001) Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. <I>Surgery <\/I>130:991-8.","DOI":"10.1067\/msy.2001.118379"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Teh BT, Esapa CT, Houlston R, <I>et al<\/I>. (1998) A family with isolated hyperparathyroidism segregating a missense MEN 1 mutation and showing loss of the wildtype allelles in the parathyroid tumors. <I>Am J Hum <\/I>63:1544-48.","DOI":"10.1086\/302097"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Goudet P, Cougard P, Verg&egrave;s B <I>et al. <\/I>(2001) Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from groupe d&rsquo;etude des n&egrave;oplasies endocriniennes multiples study group. <I>World J Surg <\/I>25: 886-890.","DOI":"10.1007\/s00268-001-0046-z"},{"key":"21","unstructured":"21. O &rsquo; Riordain DS, O&rsquo; Brian T, Grant CS, <I>et al<\/I>. (1993) Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 and 2. <I>Surgery <\/I>114:1031-39."},{"key":"22","unstructured":"22. Janson S, Tisell LE . (1994) Total parathyroidectomy and parathyroid transplantation into subcutaneous fat tissue in the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. <I>Acta Chir Austriaca <\/I>26 ( Suppl. 112) : 23-26."},{"key":"23","unstructured":"23. Cougard P, Proye C. (1994) Hyperparathyroidism and multiple endocrine neoplasia type 1 (MEN-1). <I>Acta Chir Austriaca <\/I>26 (Suppl.112): 32-35."},{"key":"24","unstructured":"24. Dralle H, Sheuemann GFW. (1994) How to handle the parathyroid glands in multiple endocrine neoplasia type 1 (MEN -1) and type 2 (MEN -2)? Surgical approach to uniglandular vs multiglandular disease in hereditary primary hyperparathyroidism. <I>Acta Chir Austriaca <\/I>26(Suppl.112): 35-38."},{"key":"25","unstructured":"25. Nilsson O, Ahlman H, Tise11 LE. (1994) Autotransplantation of parathyroid tissue into subcutaneous fat in the treatment of hyperparathyroidism in MEN -1. Abstracts of the Fifth International Workshop on multiple endocrine neoplasia. Stockholm Archipelago, Sweden, June 29-July 2, 1994."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hellmann P, Skogseid B, Oberg K, <I>et al<\/I>. (1998) Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. <I>Surgery <\/I>124:993-9.","DOI":"10.1016\/S0039-6060(98)70040-6"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Dotzenrath C, Cupisti K, Goretzki PE, <I>et al<\/I>. (2001) Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential? <I>Eur J Surg <\/I>167:173-8.","DOI":"10.1080\/110241501750099294"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Elaraj DM, Skarulis MC, Libutti SK, <I>et al. <\/I>(2003) Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. <I>Surgery <\/I>134: 858-65.","DOI":"10.1016\/S0039-6060(03)00406-9"},{"key":"29","unstructured":"29. Sokol MS, Kavolius J, Schaaf M, <I>et al. <\/I>(1993) Recurrent hyperparathyroidism from benign neoplastic seeding: A review with recommendations for management. <I>Surgery <\/I>113:456-61."},{"key":"30","unstructured":"30. Edis AJ, Van Heerden JA, Scholz DA . (1979) Results of sub-total parathyroidectomy for primary chief cell hyperplasia. <I>Surgery <\/I>86: 462-9."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Prinz RA, Gamvros OP, Sellu D, <I>et al<\/I>. (1981) Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type 1 syndrome. <I>Surgery <\/I>193:26-9.","DOI":"10.1097\/00000658-198101000-00004"},{"key":"32","unstructured":"32. Van Heerden JA, Kent RB, Sizemore GW, <I>et al<\/I>. (1983) Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndroms. Surgical experience. <I>Arch Surg <\/I>118: 533-36."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Goretzi PE, Dotzenrath C , Roeher HD . (1991) Management of primary hyperparathyroidism caused by multiglandular disease. <I>World J Surg <\/I>15: 693-7.","DOI":"10.1007\/BF01665302"},{"key":"34","unstructured":"34. Thompson NW, Sandelin K. (1994) Technical considerations in the surgical management of primary hyperparathyroidism caused by multiple gland disease (hyperplasia). <I>Acta Chir Austriaca <\/I>26 (Suppl 112):16-19."},{"key":"35","unstructured":"35. Grant CS, Weaver A. (1994) Treatment of primary parathyroid hyperplasia: representative experience at Mayo Clinic. <I>Acta Chir Austriaca <\/I>26 (Suppl 112) : 41-44."},{"key":"36","unstructured":"36. Sonoda T, Ohkawa T, Takeuci M, <I>et al<\/I>. (1968) Successfull parathyroid preservation: experimental study. <I>Surgery <\/I>64:791-95."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wells SA, Pardon JR, Dale YK, <I>et al<\/I>. (1980) Long term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. <I>Ann Surg <\/I>192: 451-58.","DOI":"10.1097\/00000658-198010000-00003"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Wagner PK, Seesko HG, Rothmund M. (1991) Replantation of cryopreserved human parathyroid tissue. <I>World J Surg <\/I>15:751-5.","DOI":"10.1007\/BF01665310"},{"key":"39","unstructured":"39. Edis AJ, Linos DA, Kao PC. (1980) Parathyroid autotransplantation to the time of reoperation for persistent hyperparathyroidism. <I>Surgery <\/I>88: 588-93."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Barnett HF, Thompson BW, Barbour GL. (1977) Parathyroid autotransplantation. <I>Arch Surg <\/I>112:373-9.","DOI":"10.1001\/archsurg.1977.01370040025004"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Feldman AL, Sharaf RN, Skarulis MC, <I>et al<\/I>. (1999) Results of heterotopic parathyroid autotransplantation: a 13 &ndash;year experience <I>Surgery <\/I>126:1042-8.","DOI":"10.1067\/msy.2099.101580"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1007\/BF01655552"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Knudsen L,Brandi L, Daugaard H, <I>et al<\/I>. (1996) Five to 19 years follow-up after total parathyroidectomy and autotransplantation of parathyroid tissue: evaluation of parathyroid function by use of ischaemic blockade manoeuvre. <I>Scand J Clin Invest <\/I>56:47-50.","DOI":"10.3109\/00365519609088587"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199711203372104"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031633"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1038\/ng0194-70"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Schuffenecker I, Billaud M, Calender A, <I>et al<\/I>. (1994) RET proto-oncogene muations in french MEN2a and FMTC families. <I>Human Mol Gent <\/I>3:1939-43.","DOI":"10.1093\/hmg\/3.11.1939"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Gagel RF, Tashjian AHJ, Cummings T, <I>et al<\/I>. (1988) The clinical outcome of prospective screening for multiple endocrine neoplasia type 2A: an 18-age year experience. <I>New Engl J Med <\/I>318:478-84.","DOI":"10.1056\/NEJM198802253180804"},{"key":"49","unstructured":"49. Mallette LE. (1994) Management of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies. <I>Endocrinol Metab Clin North Am <\/I>23:19-36."},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Herfarth KKF, Bartsch D, Doherty JM, <I>et al<\/I>. (1996) Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2a <I>Surgery <\/I>120:966-74.","DOI":"10.1016\/S0039-6060(96)80042-0"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Raue F,Kraimps JL, Dralle H, <I>et al<\/I>. (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. <I>J Int Med <\/I>238:369-73.","DOI":"10.1111\/j.1365-2796.1995.tb01212.x"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199409000-00002"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900124"},{"key":"54","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900123"},{"key":"55","unstructured":"55. Moley JF. (1996) Invited commentary. Ref 53: <I>World J Surg <\/I>20:820-21."},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Tonelli F, Marcucci T, Fratini G, <I>et al<\/I>. (2007) Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? <I>Ann Surg <\/I>246: 1075-82.","DOI":"10.1097\/SLA.0b013e31811f4467"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Henry JF, Defechereux T, Raffaelli M, <I>et al<\/I>. (2000) Supernumerary ectopic hyperfunctioning parathyroid gland: a potential pitfall in surgery for sporadic primary hyperparathyroidism. <I>Ann Chir <\/I>125: 247-52.","DOI":"10.1016\/S0003-3944(00)00247-9"},{"key":"58","unstructured":"58. Akerstrom G, Malmaeus J, Bergstrom R. (1984) Surgical anatomy of human parathyroid glands. <I>Surgery <\/I>95: 14-21."},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Aly A, Douglas M. (2003) Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. <I>ANZ J Surg <\/I>73: 284-88.","DOI":"10.1046\/j.1445-2197.2003.t01-1-02620.x"},{"key":"60","unstructured":"60. Kollmorgen CF, Aust MR, Ferreiro JA, <I>et al<\/I>. (1994) Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism. <I>Surgery <\/I>116: 111-5."},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Norton JA, Venzon DJ, Berna MJ, <I>et al<\/I>. (2008) Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. <I>Ann Surg <\/I>247:501-10.","DOI":"10.1097\/SLA.0b013e31815efda5"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Hubbard JGH, Sebag F, Maweja S, <I>et al<\/I>. (2006) Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. <I>Arch Surg <\/I>141: 235-39.","DOI":"10.1001\/archsurg.141.3.235"},{"key":"63","unstructured":"63. Arnalsteen L, Quievreux JL, Huglo D, <I>et al<\/I>. (2004) Reoperation for persistent or recurrent primary hyperparathyroidism. Seventy-seven cases among 1888 operated patients. <I>Ann Chir <\/I>129: 224-31"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Mariette C, Pellissier L, Combemale F, <I>et al<\/I>. (1998) Reoperation for persistent or recurrent primary hyperparathyroidism. <I>Langenbecks Arch Surg <\/I>383: 174-9.","DOI":"10.1007\/s004230050113"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Matsuoka S, Tominaga Y, Sato T, <I>et al<\/I>. (2007) Recurrent renal hyperparathyroidism caused by parathyromatosis. <I>World J Surg <\/I>31: 299-305.","DOI":"10.1007\/s00268-006-0391-z"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603877103"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Georgitsi M, Raitila A, Karhu A, <I>et al<\/I>. (2007) Germline <I>CDKN1B<\/I>\/p27Kip1 mutation in multiple endocrine neoplasia. <I>J Clin Endocrinol Metab <\/I>92: 3321-25.","DOI":"10.1210\/jc.2006-2843"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Clerici T, Brandle M, Lange J, <I>et al<\/I>. (2004) Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. <I>WorldJ Surg <\/I>28:187-92.","DOI":"10.1007\/s00268-003-7255-6"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Jaskowiak NT, Sugg SL, Helke J, <I>et al<\/I>. (2002) Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. <I>Arch Surg <\/I>137(6):659-68; discussion 668-9.","DOI":"10.1001\/archsurg.137.6.659"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Thompson GB, Grant CS, Perrier ND <I>et al.<\/I>(1999) Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. <I>Arch Surg <\/I>134: 699-705.","DOI":"10.1001\/archsurg.134.7.699"},{"key":"71","doi-asserted-by":"publisher","DOI":"10.1002\/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A"},{"key":"72","unstructured":"72. Khosla S, Ebeling PR, Firek AF, <I>et al<\/I>. (1993) Calcium infusion suggests a &ldquo;set-point&rdquo; abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. <I>J Clin Endocrinol Metab <\/I>76: 715-720."},{"key":"73","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012213432508"},{"key":"74","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90229-5"},{"key":"75","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.5.2042"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Szabo E, Carling T, Hessmann O <I>et al<\/I>. (2002) Loss of Heterozygosity in Parathyroid Glands of Familial Hypercalcemia with Hypercalciuria and Point Mutation in Calcium Receptor. <I>J Clin Endocrinol Metab <\/I>87(8): 3961-3965.","DOI":"10.1210\/jcem.87.8.8759"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Christensen SE, Nissen PH, Vestergaad P <I>et al<\/I>. (2008) Discriminative power of three indices of renal calcium excretion for the discrimination between familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a follow-up study on methods. <I>Clin Endocrinol<\/I>.","DOI":"10.1111\/j.1365-2265.2008.03259.x"},{"key":"78","doi-asserted-by":"publisher","DOI":"10.1097\/00019606-200112000-00006"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Marx SJ, Attie MF, Stock JL, <I>et al<\/I>. (1981) Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. <I>J Clin Endocrinol Metab <\/I>52(4):736-40.","DOI":"10.1210\/jcem-52-4-736"},{"key":"80","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90617-Y"},{"key":"81","unstructured":"81. Aida K, Koishi S, Inoue M, <I>et al<\/I>. (1995) Familial hypocalciuric hypercalcemia associated with mutation in the human Ca<SUP>2+<\/SUP>-sensing receptor gene. <I>J Clin Endocrinol Metab <\/I>80:2594-8."},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Dackiw AP, Sussman JJ, Frietsche HA, <I>et al<\/I>. (2000) Relative contribution of Technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. <I>Arch Surg <\/I>135;550-5.","DOI":"10.1001\/archsurg.135.5.550"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Marx SJ, Fraser D, Rapport A. (1985) Familial hypocalciuric hypercalcemia: mild expression of the gene in heterozygotes and severe expression in homozygotes. <I>Am J Med <\/I>78:15-22.","DOI":"10.1016\/0002-9343(85)90455-3"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Dotzenrath C, Goretzki PE, Sarbia M, <I>et al<\/I>. (2001) Parathyroid carcinoma: problems in diagnosis and the need for radical surgery even in recurrent disease. <I>Eur J Surg Oncol <\/I>27: 383-9.","DOI":"10.1053\/ejso.2001.1122"},{"key":"85","unstructured":"85. Hoetling T, Weber T, Werner J, <I>et al<\/I>. (2001) Surgical treatments of parathyroid carcinoma. <I>Oncol Rep <\/I>8: 931-4."},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Goldman L, Smyth FS. (1936) Hyperparathyroidism in siblings. <I>Ann Surg <\/I>104: 971-81.","DOI":"10.1097\/00000658-193612000-00002"},{"key":"87","doi-asserted-by":"publisher","DOI":"10.1038\/ng1048"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Bradley KJ, Hobbs MR, Buley ID, <I>et al. <\/I>(2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroidism- jaw tumour syndrome. <I>J Intern Med<\/I> 257: 18-26.","DOI":"10.1111\/j.1365-2796.2004.01421.x"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Iacobone M, Barzon L, Porzionato A, <I>et al<\/I>. (2007) Parafibromin expression, single-gland involvement, and limited parathyroidectomy in familial isolated hyperparathyroidism. <I>Surgery <\/I>142: 984-91.","DOI":"10.1016\/j.surg.2007.09.029"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Carneiro DM, Irvin GL, Inabnet WB. (2002) Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism. <I>Surgery <\/I>132: 1050-5.","DOI":"10.1067\/msy.2002.128695"},{"key":"91","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.060702"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Howell VM, Haven CJ, Kahnoski K, <I>et al<\/I>. (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. <I>J Med Genet <\/I>40: 657-63.","DOI":"10.1136\/jmg.40.9.657"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Shattuck TM, Valimaki S, Obara T, <I>et al<\/I>. (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. <I>N Engl J Med <\/I>349: 1722-9.","DOI":"10.1056\/NEJMoa031237"},{"key":"94","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900188"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Barry MK, van Heerden JA, Grant CS, <I>et al<\/I>. (1997) Is familial hyperparathyroidism a unique disease? <I>Surgery <\/I>122: 1028-33.","DOI":"10.1016\/S0039-6060(97)90205-1"},{"key":"96","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(00)88637-0"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/56\/7\/56_K09E-204\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:52:23Z","timestamp":1618296743000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/56\/7\/56_K09E-204\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":96,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k09e-204","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}